The lancet. Diabetes & endocrinology

The most recent articles from: Lancet Diabetes Endocrinol July 2017

Lancet Diabetes Endocrinol · Jul 2017

Randomized Controlled Trial Multicenter Study

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.

Long-term safety and efficacy of osteoporosis treatment are important because of the chronic nature of the disease. We aimed to assess the long-term safety and efficacy of denosumab, which is widely used for the treatment of postmenopausal women with osteoporosis. ⋯ Amgen.

read on… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.